Study finds potential HIV cure using existing cancer drug

FHS
August 30, 2023
10:50 pm

An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease.

Pharmalittle: We’re reading about Lilly’s Alzheimer’s drug, the GSK-Elsie deal, and more

Good morning, Jason Mast here filling in for Ed. Today, we’re sipping a hot cup of caffeinated black, while mulling the rise and fall and,

June 7, 2024

Private Equity Strips and Devalues Successful Hospitals, Studies Show

Private equity firms appeared to target already successful hospitals, and after acquisition, reduce hospital assets for investor profit, according to two research letters. One study

August 1, 2024

Lisata shares pipeline update of anticancer lead candidate drug

Lisata aims to finish enrolment of its Phase II trial in solid tumours by the end of 2024. Image Credit: Shutterstock / Elif Bayraktar. Lisata

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.